Cargando…
Emerging Approaches for Solid Tumor Treatment Using CAR-T Cell Therapy
Cancer immunotherapy is becoming more important in the clinical setting, especially for cancers resistant to conventional chemotherapy, including targeted therapy. Chimeric antigen receptor (CAR)-T cell therapy, which uses patient’s autologous T cells, combined with engineered T cell receptors, has...
| Autores principales: | , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
MDPI
2021
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8621681/ https://www.ncbi.nlm.nih.gov/pubmed/34830003 http://dx.doi.org/10.3390/ijms222212126 |